- Neoisoliquiritin
-
- $0.00 / 5mg
-
2023-02-24
- CAS:7014-39-3
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- neoisoliquiritin
-
- $9.80 / 1KG
-
2020-01-10
- CAS:7014-39-3
- Min. Order: 1KG
- Purity: ≥98%
- Supply Ability: 20 tons
|
| | neoisoliquiritin Basic information |
| Product Name: | neoisoliquiritin | | Synonyms: | neoisoliquiritin;1-(2,4-Dihydroxyphenyl)-3-[4-(beta-D-glucopyranosyloxy)phenyl]-2-propen-1-one;2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-[4-(β-D-glucopyranosyloxy)phenyl]- (9CI);1-[4-(β-D-glucopyranosyloxy)-2-hydroxyphenyl]-3-(4-hydroxyphenyl)- | | CAS: | 7014-39-3 | | MF: | C21H22O9 | | MW: | 418.4 | | EINECS: | | | Product Categories: | | | Mol File: | 7014-39-3.mol |  |
| | neoisoliquiritin Chemical Properties |
| Melting point | 230-232℃ | | Boiling point | 743.5±60.0 °C(Predicted) | | density | 1.528 | | pka | 7.36±0.35(Predicted) |
| | neoisoliquiritin Usage And Synthesis |
| Uses | neoisoliquiritin inhibits tumor progression by targeting GRP78-β-catenin signaling in human breast cancer cell xenograft mouse model. A cancer chemopreventive agent. | | Definition | ChEBI: Isoliquiritin is a monosaccharide derivative that is trans-chalcone substituted by hydroxy groups at positions 2' and 4' and a beta-D-glucopyranosyloxy group at position 4 respectively. It has a role as an antineoplastic agent and a plant metabolite. It is a member of chalcones, a member of resorcinols, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a trans-chalcone. |
| | neoisoliquiritin Preparation Products And Raw materials |
|